BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9446793)

  • 21. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
    Xu M; Jackson R; Adams S; Humphreys RE
    Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.
    Hammer J; Belunis C; Bolin D; Papadopoulos J; Walsky R; Higelin J; Danho W; Sinigaglia F; Nagy ZA
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4456-60. PubMed ID: 8183931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hb(64-76) epitope binds in different registers and lengths to I-Ek and I-Ak.
    Vidal K; Daniel C; Vidavsky I; Nelson CA; Allen PM
    Mol Immunol; 2000 Apr; 37(5):203-12. PubMed ID: 10930627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip.
    Gaseitsiwe S; Valentini D; Ahmed R; Mahdavifar S; Magalhaes I; Zerweck J; Schutkowski M; Gautherot E; Montero F; Ehrnst A; Reilly M; Maeurer M
    Clin Vaccine Immunol; 2009 Apr; 16(4):567-73. PubMed ID: 19225081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citrullination only infrequently impacts peptide binding to HLA class II MHC.
    Sidney J; Becart S; Zhou M; Duffy K; Lindvall M; Moore EC; Moore EL; Rao T; Rao N; Nielsen M; Peters B; Sette A
    PLoS One; 2017; 12(5):e0177140. PubMed ID: 28481943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining rules for the peptide-MHC class II interaction.
    Sinigaglia F; Hammer J
    Curr Opin Immunol; 1994 Feb; 6(1):52-6. PubMed ID: 7513526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of higher order patterns in proteins: immunologic kernels.
    Bremel RD; Homan EJ
    PLoS One; 2013; 8(7):e70115. PubMed ID: 23922927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of peptide dissociation from MHC class II molecules.
    Chaves FA; Sant AJ
    Curr Protoc Immunol; 2007 May; Chapter 18():18.14.1-18.14.11. PubMed ID: 18432989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential binding of peptides substituted at a putative C-terminal anchor residue to I-Ag7beta56Hisbeta57Ser and I-Ag7beta56Probeta57Asp.
    Oiso M; Matsushita S; Nishi T; Ishikawa T; Nakano N; Yoshida K; Kikutani H; Nishimura Y
    Immunogenetics; 1998 Apr; 47(5):411-4. PubMed ID: 9510560
    [No Abstract]   [Full Text] [Related]  

  • 31. Toward Guided Mutagenesis: Gaussian Process Regression Predicts MHC Class II Antigen Mutant Binding.
    Bell DR; Chen SH
    J Chem Inf Model; 2021 Oct; 61(10):4857-4867. PubMed ID: 34375111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EPI-peptide designer: a tool for designing peptide ligand libraries based on epitope-paratope interactions.
    Viart B; Dias-Lopes C; Kozlova E; Oliveira CF; Nguyen C; Neshich G; Chávez-Olórtegui C; Molina F; Felicori LF
    Bioinformatics; 2016 May; 32(10):1462-70. PubMed ID: 26787662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-pin peptide synthesis strategy for T cell determinant analysis.
    Maeji NJ; Bray AM; Geysen HM
    J Immunol Methods; 1990 Nov; 134(1):23-33. PubMed ID: 1700019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erratum: A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes.
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30882800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physics. Universal few-body binding.
    Modugno G
    Science; 2009 Dec; 326(5960):1640-1. PubMed ID: 20019276
    [No Abstract]   [Full Text] [Related]  

  • 36. Retraction: Designer bacteria degrades toxin.
    Nat Chem Biol; 2014 Mar; 10(3):239. PubMed ID: 24531073
    [No Abstract]   [Full Text] [Related]  

  • 37. Binding of single substituted promiscuous and designer peptides to purified DRB1*0101.
    Macklin KD; Conti-Fine BM
    Biochem Biophys Res Commun; 1998 Jan; 242(2):322-6. PubMed ID: 9446793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the allele specific Ag-binding site on murine class II MHC].
    Kajino K
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):187-203. PubMed ID: 8641675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles.
    Valmori D; Sabbatini A; Lanzavecchia A; Corradin G; Matricardi PM
    J Immunol; 1994 Mar; 152(6):2921-9. PubMed ID: 7511633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.